7.59
前日終値:
$7.88
開ける:
$7.83
24時間の取引高:
1.09M
Relative Volume:
0.74
時価総額:
$930.88M
収益:
-
当期純損益:
$-258.08M
株価収益率:
-2.76
EPS:
-2.75
ネットキャッシュフロー:
$-202.32M
1週間 パフォーマンス:
-9.96%
1か月 パフォーマンス:
-19.26%
6か月 パフォーマンス:
-58.88%
1年 パフォーマンス:
-71.83%
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
名前
Rocket Pharmaceuticals Inc
セクター
電話
646-440-9100
住所
350 FIFTH AVENUE, NEW YORK, NY
RCKT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RCKT
Rocket Pharmaceuticals Inc
|
7.59 | 930.88M | 0 | -258.08M | -202.32M | -2.75 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-12 | 開始されました | BMO Capital Markets | Outperform |
2024-12-30 | 開始されました | Wedbush | Outperform |
2024-12-18 | 開始されました | Jefferies | Buy |
2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
2024-04-02 | 開始されました | Goldman | Neutral |
2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
2023-02-01 | 開始されました | Morgan Stanley | Overweight |
2022-11-08 | 開始されました | Canaccord Genuity | Buy |
2022-11-01 | 開始されました | BTIG Research | Buy |
2022-07-08 | 開始されました | Raymond James | Outperform |
2021-10-20 | 再開されました | Cowen | Outperform |
2021-03-02 | 開始されました | Stifel | Buy |
2021-02-18 | 開始されました | Needham | Buy |
2020-12-16 | 開始されました | UBS | Buy |
2020-12-08 | ダウングレード | Oppenheimer | Outperform → Perform |
2020-07-02 | 開始されました | JP Morgan | Overweight |
2020-06-25 | 再開されました | BofA/Merrill | Buy |
2020-06-01 | 再開されました | Oppenheimer | Outperform |
2019-11-06 | 開始されました | Chardan Capital Markets | Buy |
2019-09-26 | 開始されました | Piper Jaffray | Overweight |
2019-04-23 | 開始されました | Robert W. Baird | Outperform |
2019-03-15 | 開始されました | BofA/Merrill | Buy |
2019-02-05 | 開始されました | Oppenheimer | Outperform |
2018-09-13 | 開始されました | Ladenburg Thalmann | Buy |
2018-07-10 | 開始されました | William Blair | Outperform |
すべてを表示
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
Swiss National Bank Has $1.93 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? - Yahoo Finance
Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com India
Cantor Fitzgerald maintains Overweight on Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Has $8.25 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
(RCKT) Technical Pivots with Risk Controls - Stock Traders Daily
PNC Financial Services Group Inc. Increases Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Bank of New York Mellon Corp Buys 9,949 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Fanconi Anemia Pipeline 2025: FDA Approvals and Clinical Trials - openPR
What technical indicators reveal about RCKT stock - US Post News
Steward Partners Investment Advisory LLC Has $84,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Arizona State Retirement System - Defense World
BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
(RCKT) Investment Analysis and Advice - Stock Traders Daily
BMO Capital Initiates Coverage on Rocket Pharmaceuticals With Outperform Rating, $50 Price Target - Marketscreener.com
BMO Capital Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Outperform Recommendation - Nasdaq
Rocket Pharmaceuticals: A Buy Rating for Its Pioneering Gene Therapy Approach and Promising Pipeline - TipRanks
BMO Capital sets $50 target for Rocket Pharmaceuticals stock By Investing.com - Investing.com Canada
Private Advisor Group LLC Acquires Shares of 13,199 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by New York State Common Retirement Fund - Defense World
Rhumbline Advisers Has $1.25 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Research Analysts Set Expectations for RCKT FY2025 Earnings - Defense World
Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - Insider Monkey
2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.
Handelsbanken Fonder AB Has $290,000 Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Cut to $15.00 by Analysts at The Goldman Sachs Group - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Raised to $52.00 at Scotiabank - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target Lowered to $36.00 at Canaccord Genuity Group - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 1-Year Low on Analyst Downgrade - Defense World
Rocket Pharmaceuticals Inc (NASDAQ: RCKT)’s Stock Adds 0.53%, Making It A Good Investment - Stocks Register
Scotiabank raises Rocket Pharmaceuticals target to $52 - Investing.com
What is William Blair’s Estimate for RCKT Q1 Earnings? - Defense World
What is Leerink Partnrs’ Estimate for RCKT Q2 Earnings? - Defense World
Chardan Capital Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $54.00 - Defense World
Needham & Company LLC Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $42.00 - Defense World
Rocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs - MSN
When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? - Yahoo Finance Australia
Decoding Rocket Pharmaceuticals Inc (RCKT): A Strategic SWOT Ins - GuruFocus.com
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus - MSN
Rocket Pharmaceuticals Advances Gene Therapy Pipeline - TipRanks
Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month LowHere's What Happened - MarketBeat
Promising Outlook for Rocket Pharmaceuticals: Buy Rating Reiterated with $32 Price Target - TipRanks
Rocket Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Rocket Pharmaceuticals Rings the Opening Bell - Nasdaq
Cantor Fitzgerald cuts Rocket Pharmaceuticals target to $50 By Investing.com - Investing.com Canada
Rocket Pharmaceuticals price target lowered to $54 from $62 at Chardan - TipRanks
Rocket Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Rocket Pharmaceuticals: Q4 Earnings Snapshot - The Washington Post
Rocket Pharmaceuticals Inc (RCKT) 財務データ
収益
当期純利益
現金流量
EPS
Rocket Pharmaceuticals Inc (RCKT) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Schwartz Jonathan David | See Remarks |
May 17 '24 |
Sale |
23.35 |
2,754 |
64,306 |
169,659 |
Schwartz Jonathan David | See Remarks |
Aug 16 '24 |
Sale |
18.50 |
2,710 |
50,135 |
166,949 |
Schwartz Jonathan David | See Remarks |
Nov 21 '24 |
Sale |
13.05 |
3,097 |
40,416 |
163,852 |
Patel Kinnari | See Remarks |
Feb 21 '25 |
Sale |
10.58 |
6,078 |
64,305 |
444,103 |
Wilson Martin | General Counsel |
Feb 21 '25 |
Sale |
10.58 |
3,222 |
34,089 |
150,696 |
Militello John | See Remarks |
Feb 21 '25 |
Sale |
10.58 |
2,737 |
28,957 |
65,757 |
Shah Gaurav | CEO |
Feb 21 '25 |
Sale |
10.58 |
16,303 |
172,486 |
772,680 |
大文字化:
|
ボリューム (24 時間):